Kurt Von Emster - Net Worth and Insider Trading

Kurt Von Emster Net Worth

The estimated net worth of Kurt Von Emster is at least $508 Million dollars as of 2024-11-10. Kurt Von Emster is the Director of Vaxcyte Inc and owns about 4,168,718 shares of Vaxcyte Inc (PCVX) stock worth over $445 Million. Kurt Von Emster is the Director of CRISPR Therapeutics AG and owns about 1,164,268 shares of CRISPR Therapeutics AG (CRSP) stock worth over $60 Million. Kurt Von Emster is also the Director of CymaBay Therapeutics Inc and owns about 108,406 shares of CymaBay Therapeutics Inc (CBAY) stock worth over $4 Million. Besides these, Kurt Von Emster also holds Jasper Therapeutics Inc (JSPR) . Details can be seen in Kurt Von Emster's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kurt Von Emster has not made any transactions after 2023-09-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Kurt Von Emster

To

Kurt Von Emster Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kurt Von Emster owns 6 companies in total, including Vaxcyte Inc (PCVX) , CymaBay Therapeutics Inc (CBAY) , and CRISPR Therapeutics AG (CRSP) among others .

Click here to see the complete history of Kurt Von Emster’s form 4 insider trades.

Insider Ownership Summary of Kurt Von Emster

Ticker Comapny Transaction Date Type of Owner
PCVX Vaxcyte Inc 2020-06-16 director
CBAY CymaBay Therapeutics Inc 2023-09-29 director
CRSP CRISPR Therapeutics AG 2018-12-18 director
LIMIT LIMIT 2003-06-26 10 percent owner
LIMIT LIMIT 2023-04-13 director & 10 percent owner
LIMIT LIMIT 2021-05-13 director & 10 percent owner

Kurt Von Emster Latest Holdings Summary

Kurt Von Emster currently owns a total of 4 stocks. Among these stocks, Kurt Von Emster owns 4,168,718 shares of Vaxcyte Inc (PCVX) as of June 16, 2020, with a value of $445 Million and a weighting of 87.48%. Kurt Von Emster owns 1,164,268 shares of CRISPR Therapeutics AG (CRSP) as of December 18, 2018, with a value of $60 Million and a weighting of 11.82%. Kurt Von Emster also owns 108,406 shares of CymaBay Therapeutics Inc (CBAY) as of September 29, 2023, with a value of $4 Million and a weighting of 0.69%. The other 1 stocks Jasper Therapeutics Inc (JSPR) have a combined weighting of 0.01% among all his current holdings.

Latest Holdings of Kurt Von Emster

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PCVX Vaxcyte Inc 2020-06-16 4,168,718 106.67 444,677,149
CRSP CRISPR Therapeutics AG 2018-12-18 1,164,268 51.59 60,064,586
CBAY CymaBay Therapeutics Inc 2023-09-29 108,406 32.48 3,521,027
JSPR Jasper Therapeutics Inc 2023-04-13 2,118 24.53 51,955

Holding Weightings of Kurt Von Emster


Kurt Von Emster Form 4 Trading Tracker

According to the SEC Form 4 filings, Kurt Von Emster has made a total of 1 transactions in Vaxcyte Inc (PCVX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Vaxcyte Inc is the acquisition of 12,500 shares on June 16, 2020, which cost Kurt Von Emster around $200,000.

According to the SEC Form 4 filings, Kurt Von Emster has made a total of 0 transactions in CRISPR Therapeutics AG (CRSP) over the past 5 years. The most-recent trade in CRISPR Therapeutics AG is the sale of 72,934 shares on December 18, 2018, which brought Kurt Von Emster around $2 Million.

According to the SEC Form 4 filings, Kurt Von Emster has made a total of 1 transactions in CymaBay Therapeutics Inc (CBAY) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in CymaBay Therapeutics Inc is the sale of 15,921 shares on September 29, 2023, which brought Kurt Von Emster around $249,641.

More details on Kurt Von Emster's insider transactions can be found in the Insider Trading History of Kurt Von Emster table.

Insider Trading History of Kurt Von Emster

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Kurt Von Emster Trading Performance

GuruFocus tracks the stock performance after each of Kurt Von Emster's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kurt Von Emster is 38.12%. GuruFocus also compares Kurt Von Emster's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kurt Von Emster within 3 months outperforms 4 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Kurt Von Emster's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Kurt Von Emster

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
3 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 9.19 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 9.19 LIMIT LIMIT LIMIT LIMIT LIMIT

Kurt Von Emster Ownership Network

Ownership Network List of Kurt Von Emster

No Data

Ownership Network Relation of Kurt Von Emster

Insider Network Chart

Kurt Von Emster Owned Company Details

What does Vaxcyte Inc do?

Who are the key executives at Vaxcyte Inc?

Kurt Von Emster is the director of Vaxcyte Inc. Other key executives at Vaxcyte Inc include director & President & CEO Grant Pickering , SVP & Gen Counsel & Corp Sec Mikhail Eydelman , and Chief Operating Officer Jim Wassil .

Vaxcyte Inc (PCVX) Insider Trades Summary

Over the past 18 months, Kurt Von Emster made no insider transaction in Vaxcyte Inc (PCVX). Other recent insider transactions involving Vaxcyte Inc (PCVX) include a net sale of 270,632 shares made by Grant Pickering , a net sale of 152,000 shares made by Andrew Guggenhime , and a net sale of 66,000 shares made by Jim Wassil .

In summary, during the past 3 months, insiders sold 216,881 shares of Vaxcyte Inc (PCVX) in total and bought 0 shares, with a net sale of 216,881 shares. During the past 18 months, 605,929 shares of Vaxcyte Inc (PCVX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 605,929 shares.

Vaxcyte Inc (PCVX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Vaxcyte Inc Insider Transactions

No Available Data

Kurt Von Emster Mailing Address

Above is the net worth, insider trading, and ownership report for Kurt Von Emster. You might contact Kurt Von Emster via mailing address: 601 Gateway Boulevard, Suite 350, San Francisco Ca 94080.